OVARIAN CANCER and US: recall

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label recall. Show all posts
Showing posts with label recall. Show all posts

Tuesday, January 17, 2012

Rexall Recalls Calcium Vitamin Softgels Lot On Undeclared Shellfish



"The recalled product involves only one lot number 387651-04, and has product number 45211, UPC Code 3 01220 45211 3, and expiration date 08/15."

Sunday, January 08, 2012

Jan 8th - Novartis Consumer Health Inc. Issues Voluntary Nationwide Recall of Certain Over-the-Counter Products... -- Excedrin, NoDoz, Bufferin, Gas-X Prevention



PARSIPPANY, N.J., Jan. 8, 2012 /PRNewswire/ -- Novartis Consumer Health, Inc. (NCH) announced today that it is voluntarily recalling all lots of select bottle packaging configurations of Excedrin® and NoDoz® products with expiry dates of December 20, 2014 or earlier as well as Bufferin® and Gas-X Prevention® products with expiry dates of December 20, 2013 or earlier, in the United States. NCH is taking this action as a precautionary measure because the products may contain stray tablets, capsules, or caplets from other Novartis products, or contain broken or chipped tablets...........

Sunday, October 10, 2010

abstract: Recall of intensive care unit stay in patients managed with a sedation protocol or a sedation protocol with daily sedative interruption



CONCLUSION: A notable percentage of patients discharged from the ICU report moderate to extreme pain, anxiety, and fear, and inability to sleep during their ICU stay; and 29% to 48% have no recall of specific ICU events.

Monday, September 27, 2010

Sept 27th: Lots of Epogen and Procrit Recalled Due to Glass Flakes in Vials



"According to the manufacturer, the lamellae result from the interaction of the formulation with glass vials during the shelf life of the product. However, the company states that it has found that the lamellae have a low potential to affect patients who may have received the recalled product. "To date, there have been no complaints or adverse events reported which can be directly attributed to the presence of glass lamellae," the company notes."

Wednesday, June 09, 2010

MedEffect Canada - 2010 - Advisories, Warnings and Recalls



June

* CIPROFLOXACIN INJECTION - Voluntary Recall
o Notice to Hospitals [2010-06-09]


per Wiki: "Ciprofloxacin is marketed worldwide with over three hundred different brand names. In the United States, Canada and the UK, it is marketed as Baycip, Ciloxan, Ciflox, Cipro, Cipro XR, Cipro XL, Ciproxin and most recently, Proquin. Additionally, ciprofloxacin is available as a generic drug under a variety of different brand names and is also available for limited use in veterinary medicine."